|
2023 |
Real-time recombinase-aided amplification assay for rapid amplification of the IS1081 gene of Mycobacterium tuberculosis |
Yuanyuan Liu,Weicong Ren,Zhongtan Xue,Yuedong Miao,Wei Wang,Xuxia Zhang,Cong Yao,Yuanyuan Shang,Shanshan Li,Fengling Mi,Yu Pang |
European Journal of Clinical Microbiology & Infectious Diseases |
37256455 |
10.1007/s10096-023-04626-5 |
Real-time recombinase-aided amplification assay for rapid amplification of the IS1081 gene of Mycobacterium tuberculosis
Author(s):
Yuanyuan Liu,Weicong Ren,Zhongtan Xue,Yuedong Miao,Wei Wang,Xuxia Zhang,Cong Yao,Yuanyuan Shang,Shanshan Li,Fengling Mi,Yu Pang
Journal:
European Journal of Clinical Microbiology & Infectious Diseases
Year:
2023
Abstract:
Mycobacterium tuberculosis (MTB), the etiological agent of tuberculosis (TB), is the leading cause of death due to a single infectious agent worldwide. Rapid and accurate diagnosis of MTB is critical for controlling TB especially in resource-limited countries, since any diagnosis delay increases the chances of transmission. Here, a real-time recombinase-aided amplification (RAA) assay targeting conserved positions in IS1081 gene of MTB, is successfully established to detect MTB. The intact workflow was completed within 30 min at 42 °C with no cross-reactivity observed for non-tuberculous mycobacteria and other clinical bacteria, and the detection limit for recombinant plasmid of MTB IS1081 was 163 copies/reaction at 95% probability, which was approximately 1.5-fold increase in analytical sensitivity for the detection of MTB, compared to conventional quantitative real-time PCR (qPCR; 244 copies/reaction). Furthermore, the result of clinical performance evaluation revealed an increased sensitivity of RAA assay relative to qPCR was majorly noted in the specimens with low bacteria loads. Our results demonstrate that the developed real-time RAA assay is a convenient, sensitive, and low-cost diagnostic tool for the rapid detection of MTB.
|